GlassScriptPhysician profile
Ashlea B Lamberth
NPI 1700820388
$9,136.07
in general payments reported to CMS, 2019-2025
43 companies · $2,018 in 2025
The $2,018 reported for 2025 was more than what 94% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,455 · 2022: $1,546 · 2023: $2,049 · 2024: $2,068 · 2025: $2,018.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,136.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,135.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,866.15 | 2021-2025 | |
| Novo Nordisk INC | $1,519.07 | 2021-2025 | Ozempic, Rybelsus, Wegovy |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,203.18 | 2021-2025 | Xifaxan, Trulance, Cycloset |
| Lilly USA, LLC | $633.17 | 2021-2025 | Mounjaro, Zepbound, Jardiance |
| Astrazeneca Pharmaceuticals LP | $385.67 | 2021-2025 | Airsupra, Farxiga, Breztri |
| Takeda Pharmaceuticals U.S.A., INC. | $364.84 | 2021-2025 | Trintellix |
| Glaxosmithkline, LLC. | $307.85 | 2021-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Pfizer INC. | $252.20 | 2021-2025 | |
| Otsuka America Pharmaceutical, INC. | $180.55 | 2021-2025 | Rexulti |
| Axsome Therapeutics, INC. | $179.06 | 2023-2025 | Auvelity |
| Astellas Pharma US INC | $168.14 | 2021-2025 | Veozah, Myrbetriq |
| Amarin Pharma, INC. | $166.76 | 2021-2022 | |
| Corcept Therapeutics | $166.56 | 2025 | Korlym |
| Bayer Healthcare Pharmaceuticals INC. | $164.03 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $153.42 | 2024-2025 | Caplyta |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashlea Lamberth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.